RNAimmune Revenue and Competitors

Location

$12.4M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • RNAimmune's estimated annual revenue is currently $2.2M per year.(i)
  • RNAimmune's estimated revenue per employee is $77,500
  • RNAimmune's total funding is $12.4M.

Employee Data

  • RNAimmune has 29 Employees.(i)
  • RNAimmune grew their employee count by 12% last year.

RNAimmune's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CMOReveal Email/Phone
3
Section Chief Medical OfficerReveal Email/Phone
4
VPReveal Email/Phone
5
Chief Business OfficerReveal Email/Phone
6
Director Scientific ProgramsReveal Email/Phone
7
Associate Director, ChemistryReveal Email/Phone
8
Senior Scientist IIReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$99.4M45840%N/AN/A
#2
$20.6M13322%N/AN/A
#3
$156.1M146-70%$145MN/A
#4
$3.5M45-25%$150MN/A
#5
$1.6M210%$459.5MN/A
#6
$67.3M31016%$180.7MN/A
#7
$8.5M55-2%N/AN/A
#8
$256.3M10259%$168.5MN/A
#9
$2.8M18-33%N/AN/A
#10
$9.1M59-9%N/AN/A
Add Company

What Is RNAimmune?

keywords:N/A

$12.4M

Total Funding

29

Number of Employees

$2.2M

Revenue (est)

12%

Employee Growth %

N/A

Valuation

N/A

Accelerator

RNAimmune News

2022-04-19 - Codex DNA Demonstrates Simple, Scalable, and Cell-Free ...

RNAimmune will showcase the design and development of their novel Pan-Ras mRNA vaccine for cancer therapy at the conference and also highlight...

2022-03-30 - Money Moves: Meaningful Gigs bagged $6M to grow its ...

RNAimmune also completed a $2.3 million angel round in August of 2020 — the year of its founding — and a $10 million seed round last April. “The...

2022-03-30 - RNAimmune Secures $27 Million Series A Round of ...

RNAimmune is a biopharmaceutical company specializing in discovery and development of messenger RNA (mRNA) therapeutics and vaccines. The...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2M2932%$7M
#2
$7.5M290%N/A
#3
$5M297%N/A
#4
$2.9M29N/AN/A
#5
$1.7M29N/AN/A